JP2010521442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521442A5 JP2010521442A5 JP2009553196A JP2009553196A JP2010521442A5 JP 2010521442 A5 JP2010521442 A5 JP 2010521442A5 JP 2009553196 A JP2009553196 A JP 2009553196A JP 2009553196 A JP2009553196 A JP 2009553196A JP 2010521442 A5 JP2010521442 A5 JP 2010521442A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- nsaid
- glycol ether
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0704846.5A GB0704846D0 (en) | 2007-03-13 | 2007-03-13 | Topical pharmaceutical formulation |
| PCT/GB2008/000540 WO2008110741A2 (en) | 2007-03-13 | 2008-02-15 | Topical pharmaceutical formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521442A JP2010521442A (ja) | 2010-06-24 |
| JP2010521442A5 true JP2010521442A5 (enExample) | 2011-04-14 |
Family
ID=37988913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553196A Pending JP2010521442A (ja) | 2007-03-13 | 2008-02-15 | 局所製剤処方 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8541470B2 (enExample) |
| EP (2) | EP2131813B1 (enExample) |
| JP (1) | JP2010521442A (enExample) |
| CN (1) | CN101663022A (enExample) |
| AU (1) | AU2008224735B2 (enExample) |
| BR (1) | BRPI0808887A2 (enExample) |
| CA (1) | CA2680074C (enExample) |
| CO (1) | CO6220926A2 (enExample) |
| DK (1) | DK2131813T3 (enExample) |
| ES (1) | ES2391914T3 (enExample) |
| GB (1) | GB0704846D0 (enExample) |
| MX (1) | MX2009009758A (enExample) |
| MY (1) | MY149545A (enExample) |
| NZ (1) | NZ579895A (enExample) |
| PL (1) | PL2131813T3 (enExample) |
| PT (1) | PT2131813E (enExample) |
| RU (1) | RU2468794C2 (enExample) |
| SG (1) | SG179480A1 (enExample) |
| TW (1) | TWI367110B (enExample) |
| UA (1) | UA100509C2 (enExample) |
| WO (1) | WO2008110741A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3300721T4 (da) * | 2003-11-20 | 2025-03-03 | Novo Nordisk As | Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger |
| JO3032B1 (ar) | 2008-10-17 | 2016-09-05 | Xenon Pharmaceuticals Inc | مركبات سبيرو – اوكسندول وإستعمالاتها كعوامل علاجية. |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| KR20120099429A (ko) | 2009-10-14 | 2012-09-10 | 제논 파마슈티칼스 인크. | 스피로-옥스인돌 화합물의 합성 방법 |
| WO2011106729A2 (en) | 2010-02-26 | 2011-09-01 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| HK1205114A1 (en) | 2012-04-12 | 2015-12-11 | Xenon Pharmaceuticals Inc. | Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
| KR102235264B1 (ko) * | 2013-01-14 | 2021-04-02 | 인퍼스트 헬스케어 리미티드 | 고용체 조성물들 및 심각한 통증에서의 이들의 용도 |
| EP2943183A1 (en) * | 2013-01-14 | 2015-11-18 | InFirst Healthcare Limited | Compositions and methods for treating severe pain |
| CA2898017A1 (en) * | 2013-02-04 | 2014-08-07 | Infirst Healthcare Limited | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| US9012402B1 (en) | 2014-06-11 | 2015-04-21 | James Blanchard | Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation |
| US10561627B2 (en) | 2014-12-31 | 2020-02-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films |
| US11007161B1 (en) | 2014-12-31 | 2021-05-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films |
| US10596117B1 (en) | 2014-12-31 | 2020-03-24 | Eric Morrison | Lipoleosomes as carriers for aromatic amide anesthetic compounds |
| WO2016127068A1 (en) | 2015-02-05 | 2016-08-11 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
| GB201502845D0 (en) * | 2015-02-20 | 2015-04-08 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| FR3041534B1 (fr) * | 2015-09-30 | 2019-03-15 | Vetoquinol Sa | Composition de nettoyant auriculaire |
| GB201609968D0 (en) * | 2016-06-07 | 2016-07-20 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| US10100060B2 (en) | 2016-06-16 | 2018-10-16 | Xenon Pharmaceuticals Inc. | Asymmetric synthesis of funapide |
| CN110545796A (zh) * | 2017-03-07 | 2019-12-06 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 用于活性化合物的局部递送系统 |
| US10821075B1 (en) | 2017-07-12 | 2020-11-03 | James Blanchard | Compositions for topical application of a medicaments onto a mammalian body surface |
| KR102665710B1 (ko) | 2017-08-24 | 2024-05-14 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 그 용도 |
| JP7761567B2 (ja) | 2020-02-18 | 2025-10-28 | ノヴォ ノルディスク アー／エス | 医薬製剤 |
| GB2596286B (en) | 2020-06-20 | 2023-01-25 | Francis Davis Adrian | Adherence to topical therapy |
| WO2022023348A1 (en) | 2020-07-27 | 2022-02-03 | Incanthera (R&D) Ltd | Topical formulation |
| GB2597526A (en) | 2020-07-27 | 2022-02-02 | Incanthera R&D Ltd | Topical formulation |
| GB202012836D0 (en) | 2020-08-17 | 2020-09-30 | Futura Medical Developments Ltd | Topical composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06104624B2 (ja) | 1986-05-07 | 1994-12-21 | 太郎 小木曽 | 経皮吸収剤 |
| PE20011092A1 (es) | 2000-02-14 | 2001-11-12 | Procter & Gamble | Composiciones para el suministro topico de un agente farmaceuticamente activo que tiene reducida irritacion de la piel |
| DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
| AR041021A1 (es) * | 2002-08-22 | 2005-04-27 | Novartis Consumer Health Sa | Composicion topica |
| US7132452B2 (en) * | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
| WO2005027977A2 (en) * | 2003-09-22 | 2005-03-31 | Agis Industries (1983) Ltd. | Diclofenac compositions for the treatment of skin disorders |
| EP1588697A1 (en) | 2004-04-16 | 2005-10-26 | Kurt H. Prof. Dr. Bauer | Emulsion gel for topical application of pharmaceuticals |
| US20050244522A1 (en) | 2004-04-30 | 2005-11-03 | Carrara Dario Norberto R | Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents |
-
2007
- 2007-03-13 GB GBGB0704846.5A patent/GB0704846D0/en not_active Ceased
-
2008
- 2008-02-15 CA CA2680074A patent/CA2680074C/en active Active
- 2008-02-15 PT PT08709428T patent/PT2131813E/pt unknown
- 2008-02-15 CN CN200880007936A patent/CN101663022A/zh active Pending
- 2008-02-15 BR BRPI0808887-0A patent/BRPI0808887A2/pt not_active Application Discontinuation
- 2008-02-15 EP EP08709428A patent/EP2131813B1/en not_active Not-in-force
- 2008-02-15 ES ES08709428T patent/ES2391914T3/es active Active
- 2008-02-15 RU RU2009136228/15A patent/RU2468794C2/ru active
- 2008-02-15 WO PCT/GB2008/000540 patent/WO2008110741A2/en not_active Ceased
- 2008-02-15 EP EP12154983A patent/EP2452671A2/en not_active Withdrawn
- 2008-02-15 AU AU2008224735A patent/AU2008224735B2/en not_active Ceased
- 2008-02-15 US US12/530,960 patent/US8541470B2/en active Active
- 2008-02-15 DK DK08709428.0T patent/DK2131813T3/da active
- 2008-02-15 NZ NZ579895A patent/NZ579895A/en not_active IP Right Cessation
- 2008-02-15 JP JP2009553196A patent/JP2010521442A/ja active Pending
- 2008-02-15 SG SG2012017497A patent/SG179480A1/en unknown
- 2008-02-15 PL PL08709428T patent/PL2131813T3/pl unknown
- 2008-02-15 UA UAA200910111A patent/UA100509C2/ru unknown
- 2008-02-15 MX MX2009009758A patent/MX2009009758A/es active IP Right Grant
- 2008-02-15 MY MYPI20093774A patent/MY149545A/en unknown
- 2008-02-20 TW TW097105840A patent/TWI367110B/zh not_active IP Right Cessation
-
2009
- 2009-10-08 CO CO09111579A patent/CO6220926A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521442A5 (enExample) | ||
| RU2009136228A (ru) | Фармацевтическая композиция для топического применения | |
| JP5734479B2 (ja) | ジクロフェナクの新規な非水性外用溶液およびそれを調製するためのプロセス | |
| JP2015527386A5 (enExample) | ||
| JP2010513500A5 (enExample) | ||
| RU2012137785A (ru) | Лечение респираторных заболеваний | |
| CA2768586A1 (en) | Dermal formulations of dp2 receptor antagonists | |
| JP2016508158A5 (enExample) | ||
| JP2008540394A5 (enExample) | ||
| JP2014185132A5 (enExample) | ||
| JP2012530719A5 (enExample) | ||
| RS53887B1 (sr) | Jedinjenje sa topikalnom primenom za aktinične keratoze | |
| JP2013515020A5 (enExample) | ||
| CN102770121B (zh) | 包含溶剂混合物和维生素d衍生物或类似物的药物组合物 | |
| TW201444553A (zh) | 外用醫藥組成物 | |
| JP2014515407A5 (enExample) | ||
| JP2018505905A (ja) | 局所医薬製剤 | |
| JP2014510156A5 (enExample) | ||
| JP5642658B2 (ja) | 非水性貼付剤 | |
| WO2014091729A1 (ja) | 基剤、及び皮膚外用剤 | |
| JP2008522972A5 (enExample) | ||
| JP6253495B2 (ja) | ロキソプロフェンを含有する外用剤組成物 | |
| WO2015016698A1 (es) | Composición farmacéutica con agentes antiinflamatorios y proceso de producción | |
| CN104415024B (zh) | 含双氯芬酸的巴布剂、及其组合物和制备方法 | |
| TW200824717A (en) | Composition for external application to skin and skin regeneration promoter |